Together, our analysis indicated that although deletion of PTEN and amplification many other Akt pathway genes were observed in neuroendocrine PCa samples, there was no significant difference in the mean mRNA levels of the Akt isoforms between the altered group of patients vs. the un-altered group. The gene discussed is AKT1; the disease is posterior cortical atrophy.